Orexin receptor antagonists
Suvorexant
The FDA lists this product in 4 strengths and forms.
Composition
- Active ingredients
- SUVOREXANT 15MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA219386.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Suvorexant
- Drug class
- Orexin receptor antagonists
- Dosage form
- Tablet
- Applicant
- Hetero Labs LTD Unit III
- Status
- Tentative approval
- FDA approval
- 22 Dec 2025
- Application
- ANDA219386-003
- RxCUI
- 1547099